# Nitroglycerine Versus Dexmedetomidine Infusion in Intraoperative Management of Uncontrolled Hypertension

> **NCT04953156** · — · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 77 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nitroglycerin
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT04953156
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-03
- **Primary completion:** 2022-11-20
- **Final completion:** 2022-12-10
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04953156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04953156, "Nitroglycerine Versus Dexmedetomidine Infusion in Intraoperative Management of Uncontrolled Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04953156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*